title: [Long-term use of proton pump inhibitors: who needs prophylaxis?].
abstract: Proton pump inhibitors (PPI) are among the most frequently prescribed drugs worldwide. Recently, several side effects of chronic PPI therapy have been identified. Reduced intestinal absorption of vitamin B12 or calcium, an increased rate of bone fractures, an interference with the metabolism of other drugs (e.g., clopidogrel), and an increased incidence of Clostridium difficile-associated colitis are discussed. So far, data on such side effects of PPI are mainly supported by retrospective and/or uncontrolled studies. Therefore, a definitive estimation of the real risk of long-term PPI medication is not yet possible. However, since chronic treatment with PPI may lead to severe side effects, it is necessary to keep the established indications for these drugs (peptic ulcer therapy, gastro-esophageal reflux disease, prophylaxis of mucosal lesions by potentially ulcerogenic drugs) in mind. PPI therapy as stress ulcer prophylaxis should be confined to risk groups and risk situations. Long-term treatment with PPI requires repeated confirmation of a persisting indication, choice of the lowest effective dose, and-if applicable-an interval or "on demand" treatment.
authors: Medizinische Klinik und Poliklinik II, Schwerpunkt Gastroenterologie, Oberdürrbacher Str. 6-8, 97080, Würzburg, Deutschland. scheurlen_m@klinik.uni-wuerzburg.de
authors: M
authors: M
authors: Scheurlen
mesh_terms: D003092:Colitis / Q000139:chemically induced* / Q000517:prevention & control; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced* / Q000517:prevention & control; D019317:Evidence-Based Medicine; D050723:Fractures, Bone / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D008137:Longitudinal Studies; D054328:Proton Pump Inhibitors / Q000009:adverse effects*; D018570:Risk Assessment
chemical_list: D054328:Proton Pump Inhibitors
references: Am J Gastroenterol. 2006 Oct;101(10):2200-5
references: 16952283
references: J Am Med Dir Assoc. 2008 Mar;9(3):162-7
references: 18294598
references: N Engl J Med. 2010 Nov 11;363(20):1909-17
references: 20925534
references: BMJ. 2012 Jan 30;344:e372
references: 22294756
references: Postgrad Med. 2001 Sep;110(3):42-4, 47-8, 51-3
references: 11570205
references: Dig Dis Sci. 2011 Apr;56(4):931-50
references: 21365243
references: Bone. 2011 Apr 1;48(4):768-76
references: 21185417
references: Herz. 2010 Dec;35(8):558-64
references: 21107514
references: Arch Intern Med. 2010 May 10;170(9):784-90
references: 20458086
references: Clin Infect Dis. 2006 Nov 15;43(10):1272-6
references: 17051491
references: Heart. 2013 Apr;99(8):520-7
references: 22851683
references: Drug Metab Dispos. 2004 Aug;32(8):821-7
references: 15258107
references: Am J Med. 1998 May;104(5):422-30
references: 9626024
references: Am J Gastroenterol. 2010 Dec;105(12):2533-49
references: 21131924
references: Dtsch Med Wochenschr. 2012 Apr;137(15):799-801
references: 22492416
references: Int J Clin Pract. 2012 Aug;66(8):767-773
references: 22805269
references: Dtsch Med Wochenschr. 2010 Oct;135(41):2033-6
references: 20925012
references: Clin Endocrinol (Oxf). 2008 Aug;69(2):338-41
references: 18221401
references: Am J Gastroenterol. 2012 Jul;107(7):1001-10
references: 22710578
references: Am J Gastroenterol. 2009 Mar;104 Suppl 2:S27-32
references: 19262544
references: Gastroenterology. 2010 Oct;139(4):1115-27
references: 20727892
references: Z Gastroenterol. 2010 Sep;48(9):1156-63
references: 20839167
references: J Am Coll Cardiol. 2008 Oct 28;52(18):1502-17
references: 19017521